BioMarin Pharmaceutical News - BMRN

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
BioMarin Pharmaceutical Inc BMRN NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 67.36 68.21 67.01 67.38 67.36 19:08:49
more quote information »

Recent News

Date Time Source Heading
10/09/201908:31PRNUSBioMarin to Host Third Quarter 2019 Financial Results..
10/07/201908:31PRNUSBioMarin Promotes Lon Cardon, Ph.D. to Chief Scientific..
10/01/201908:30PRNUSBioMarin to Participate in Jefferies Gene Therapy/Editing..
9/26/201908:31PRNUSBioMarin, Pioneer in Phenylketonuria (PKU) Therapies,..
9/18/201918:48EDGARStatement of Changes in Beneficial Ownership (4)
9/09/201916:05PRNUSBioMarin to Participate in Morgan Stanley 17th Annual Global..
8/28/201908:30PRNUSBioMarin to Participate in Morgan Stanley 17th Annual Global..
8/08/201919:35EDGARStatement of Changes in Beneficial Ownership (4)
8/02/201906:12EDGARQuarterly Report (10-q)
8/01/201916:17EDGARCurrent Report Filing (8-k)
8/01/201916:05PRNUSBioMarin Announces Second Quarter 2019 Financial Results
7/16/201908:30PRNUSBioMarin to Host Second Quarter 2019 Financial Results..
7/12/201919:10EDGARStatement of Changes in Beneficial Ownership (4)
7/11/201918:41EDGARStatement of Changes in Beneficial Ownership (4)
7/11/201918:02EDGARInitial Statement of Beneficial Ownership (3)
7/10/201917:01EDGARCurrent Report Filing (8-k)
7/09/201908:31PRNUSBioMarin Appoints Pharmaceutical Veteran and Former J & J..
7/08/201908:01PRNUSBioMarin Plans Regulatory Submissions for Marketing..
6/26/201908:31PRNUSBioMarin Announces Acceptance of Late Breaking Abstract at..
6/21/201911:30PRNUSBioMarin Earns Milestone Payments from Pfizer for TALZENNA®..
6/19/201912:28EDGARStatement of Changes in Beneficial Ownership (4)
6/18/201908:31PRNUSBioMarin Announces New England Journal of Medicine Publishes..
6/10/201919:04EDGARStatement of Changes in Beneficial Ownership (4)
6/07/201919:15EDGARStatement of Changes in Beneficial Ownership (4)
6/07/201919:09EDGARStatement of Changes in Beneficial Ownership (4)
6/07/201918:53EDGARStatement of Changes in Beneficial Ownership (4)
6/07/201918:52EDGARStatement of Changes in Beneficial Ownership (4)
6/07/201918:49EDGARStatement of Changes in Beneficial Ownership (4)
6/07/201917:04EDGARCurrent Report Filing (8-k)
6/06/201918:18EDGARStatement of Changes in Beneficial Ownership (4)
6/06/201918:15EDGARStatement of Changes in Beneficial Ownership (4)
6/06/201918:13EDGARStatement of Changes in Beneficial Ownership (4)
6/06/201918:11EDGARStatement of Changes in Beneficial Ownership (4)
6/06/201918:07EDGARStatement of Changes in Beneficial Ownership (4)
6/06/201917:59EDGARStatement of Changes in Beneficial Ownership (4)
6/06/201917:57EDGARStatement of Changes in Beneficial Ownership (4)
6/06/201917:54EDGARStatement of Changes in Beneficial Ownership (4)
6/06/201917:48EDGARStatement of Changes in Beneficial Ownership (4)
6/06/201917:11EDGARStatement of Changes in Beneficial Ownership (4)
6/06/201917:08EDGARStatement of Changes in Beneficial Ownership (4)
6/05/201908:30PRNUSBioMarin to Participate in Goldman Sachs 40th Annual Global..
6/04/201908:30PRNUSBioMarin Announces Approval of Vimizim® (elosulfase alfa) in..
5/28/201906:55PRNUSBioMarin Announces that Phase 3 Cohort of Valoctocogene..
5/28/201906:50PRNUSBioMarin Provides 3 Years of Clinical Data from Ongoing..
5/27/201916:00PRNUSBioMarin to Host Conference Call Tuesday, May 28, 2019 to..
5/16/201908:30PRNUSBioMarin to Participate in 2019 RBC Capital Markets Global..
5/14/201919:16EDGARStatement of Changes in Beneficial Ownership (4)
5/13/201919:09EDGARStatement of Changes in Beneficial Ownership (4)
5/08/201908:30PRNUSBioMarin to Participate in Bank of America Merrill Lynch..
5/06/201910:12PRNUSEuropean Commission Approves Palynziq® (pegvaliase..
See more news about this stock »
Your Recent History
NASDAQ
BMRN
BioMarin P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191014 04:49:12